NeuroMetrix Inc. (NASDAQ: NURO) Stock Upgraded at Zacks Investment Research

Analysts at Zacks Investment Research upgraded shares of NeuroMetrix Inc. (NASDAQ: NURO) from Sell to Hold today.With a rating of Hold on the stock, NeuroMetrix Inc. has a 52-week high of $3.80. The one-year price target of $4.50 is higher than the opening price of $1.56, that has caused a number of other analysts to report on the company recently. Stock prices often shift to the upside on recommendations and new price targets of professional brokerage firms.

U.S. stocks on Monday closed mostly flat, after trading firmly higher, in a volatile session ahead of the start of a pair of closely watched central-bank policy meetings.

The Dow Jones Industrial Average DJIA, -0.02% closed down 3.63 points at 18,120.17.

The blue-chip gauge had been up by as much as 131 points earlier and traded within a 162-point range.

The S&P 500 SPX, +0.00% slipped 0.04 points to close at 2,139.12, after trading within an 18-point range

Meanwhile, the Nasdaq Composite Index COMP, -0.18% declined 9.54 points, or 0.2%, to close at 5,235.03.

Earlier, the Nasdaq Composite Index had been up by as many as 37 points and traded with a 58-point range

Shares of NeuroMetrix Inc. (NASDAQ: NURO) opened at $1.56 yesterday trading between $1.54 and $1.56, and last traded at $1.55, which represents a dip of $0.01 from the previous closing price.

NeuroMetrix Inc. (NASDAQ: NURO) currently has a market cap of 7.93M.

7,407 shares traded hands yesterday, 27 percent below normal, out of a total float 4,865,000. Trading volume is likely to increase in the next few days as investors often use swings in trading volume to identify substantial volume accumulation or dissemination by institutional investors.

As with all possible breakouts, investors watch for volume to be at least 40%-50% above normal on the breakout to indicate that fund managers and other professional investors are jumping in.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these retain teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

With that in mind, NeuroMetrix Inc. (NASDAQ: NURO) now has a 50-day MA of $1.48 and 200-day MA of $1.68. It has traded in a 52-week range between $1.35 – 3.8000 and today’s last price is 0.59% lower than the 52 week high of $3.80.

Earnings growth is a critical factor to research when investing in stocks and investors identify companies that have raised their earnings at least 25% or more for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.